Renalytix AI plc (LON:RENX)
1.90p
Spriggl Score: Weak— sign in to explore; full breakdown with Premium
Last 30 trading days
Spriggl AI Verdict
“Unique kidney test faces cash crunch; success hinges on accelerating US hospital adoption before funds run out.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Renalytix AI plc
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management of kidney diseases in Europe and the United States. It offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines v…
- Sector:
- Healthcare
- Industry:
- Health Information Services
- Market Cap:
- £8.3M
Recent dividends
No recent dividends recorded.
Get the full Spriggl analysis — free
A free Spriggl account gets you the screener, a watchlist, AI verdicts and a free full report every day — across Renalytix AI plc and 1,500+ UK and US stocks. The full score breakdown and AI analysis come with Premium.
Start free